Self-Crosslinking Lipopeptide/DNA/PEGylated Particles: A New Platform for DNA Vaccination Designed for Assembly in Aqueous Solution

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2018 Sep 10

PMID 30195787

Citations 5

Authors

Joan K Ho

Paul J White

Colin W Pouton

Affiliations

Soon will be listed here.

Abstract

Delivery of plasmids for gene expression in vivo is an inefficient process that requires improvement and optimization to unlock the clinical potential of DNA vaccines. With ease of manufacture and biocompatibility in mind, we explored condensation of DNA in aqueous solution with a self-crosslinking, endosome-escaping lipopeptide (LP), stearoyl-Cys-His-His-Lys-Lys-Lys-amide (stearoyl-CHK), to produce cationic LP/DNA complexes. To test whether poly(ethylene glycol) (PEG)-ylation of these cationic complexes to neutralize the surface charge would improve the distribution, gene expression, and immune responses poly(ethylene glycol), these LP/DNA complexes were combined with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG). Fluorescence imaging illustrated that the cationic complexes exhibited the highest degree of localization and lowest degree of dispersion throughout the injected muscle, suggesting impaired mobility of cationic particles upon administration. Nanoluciferase reporter assays over a 90-day period demonstrated that gene expression levels in muscle were highest for PEGylated particles, with over a 200-fold higher level of expression than the cationic particles observed at 30 days. Humoral and cell-mediated immune responses were evaluated in vivo after injection of an ovalbumin expression plasmid. PEGylation improved both immune responses to the DNA complexes in mice. Overall, this suggests that PEGylation of cationic lipopeptide complexes can significantly improve both the transgene expression and immunogenicity of intramuscular DNA vaccines.

Citing Articles

Lipopeptides as tools in catalysis, supramolecular, materials and medicinal chemistry.

Vicente-Garcia C, Colomer I Nat Rev Chem. 2023; 7(10):710-731.

PMID: 37726383 DOI: 10.1038/s41570-023-00532-8.

Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection.

Takanashi A, Pouton C, Al-Wassiti H Mol Pharm. 2023; 20(8):3876-3885.

PMID: 37491979 PMC: 10411422. DOI: 10.1021/acs.molpharmaceut.2c01024.

The Progress of Non-Viral Materials and Methods for Gene Delivery to Skeletal Muscle.

Cui Z, Jiao Y, Pu L, Tang J, Wang G Pharmaceutics. 2022; 14(11).

PMID: 36365246 PMC: 9695315. DOI: 10.3390/pharmaceutics14112428.

Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies.

Lim M, Badruddoza A, Firdous J, Azad M, Mannan A, Al-Hilal T Pharmaceutics. 2020; 12(1).

PMID: 31906277 PMC: 7022884. DOI: 10.3390/pharmaceutics12010030.

At the Intersection of Biomaterials and Gene Therapy: Progress in Non-viral Delivery of Nucleic Acids.

Uludag H, Ubeda A, Ansari A Front Bioeng Biotechnol. 2019; 7:131.

PMID: 31214586 PMC: 6558074. DOI: 10.3389/fbioe.2019.00131.

References

Thompson B, Chilton P, Ward J, Evans J, Mitchell T . The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells. J Leukoc Biol. 2005; 78(6):1273-80. DOI: 10.1189/jlb.0305172. View

Jeffs L, Palmer L, Ambegia E, Giesbrecht C, Ewanick S, MacLachlan I . A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA. Pharm Res. 2005; 22(3):362-72. DOI: 10.1007/s11095-004-1873-z. View

Plank C, Tang M, Wolfe A, Szoka Jr F . Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. Hum Gene Ther. 1999; 10(2):319-32. DOI: 10.1089/10430349950019101. View

Finsinger D, Remy J, Erbacher P, Koch C, Plank C . Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery. Gene Ther. 2000; 7(14):1183-92. DOI: 10.1038/sj.gt.3301227. View

Condon C, Watkins S, Celluzzi C, Thompson K, Falo Jr L . DNA-based immunization by in vivo transfection of dendritic cells. Nat Med. 1996; 2(10):1122-8. DOI: 10.1038/nm1096-1122. View

Peng B, Zhao Y, Xu L, Xu Y . Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity. Vaccine. 2007; 25(11):2064-73. DOI: 10.1016/j.vaccine.2006.11.042. View

Yang Z, Zhu J, Sriadibhatla S, Gebhart C, Alakhov V, Kabanov A . Promoter- and strain-selective enhancement of gene expression in a mouse skeletal muscle by a polymer excipient Pluronic P85. J Control Release. 2005; 108(2-3):496-512. DOI: 10.1016/j.jconrel.2005.08.015. View

Mills C, Kincaid K, Alt J, Heilman M, Hill A . M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000; 164(12):6166-73. DOI: 10.4049/jimmunol.164.12.6166. View

Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E . PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 1999; 6(4):595-605. DOI: 10.1038/sj.gt.3300900. View

10.

Bello-Roufai M, Lambert O, Pitard B . Relationships between the physicochemical properties of an amphiphilic triblock copolymers/DNA complexes and their intramuscular transfection efficiency. Nucleic Acids Res. 2006; 35(3):728-39. PMC: 1807968. DOI: 10.1093/nar/gkl860. View

11.

Satkauskas S, Bureau M, Mahfoudi A, Mir L . Slow accumulation of plasmid in muscle cells: supporting evidence for a mechanism of DNA uptake by receptor-mediated endocytosis. Mol Ther. 2001; 4(4):317-23. DOI: 10.1006/mthe.2001.0465. View

12.

Corr M, von Damm A, Lee D, Tighe H . In vivo priming by DNA injection occurs predominantly by antigen transfer. J Immunol. 1999; 163(9):4721-7. View

13.

Fu T, Ulmer J, Caulfield M, Deck R, Friedman A, Wang S . Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med. 1997; 3(6):362-71. PMC: 2230213. View

14.

Choi Y, Liu F, Kim J, Choi Y, Park J, Kim S . Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. J Control Release. 1998; 54(1):39-48. DOI: 10.1016/s0168-3659(97)00174-0. View

15.

Casares S, Inaba K, Brumeanu T, Steinman R, Bona C . Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J Exp Med. 1997; 186(9):1481-6. PMC: 2199124. DOI: 10.1084/jem.186.9.1481. View

16.

Le Bihan O, Chevre R, Mornet S, Garnier B, Pitard B, Lambert O . Probing the in vitro mechanism of action of cationic lipid/DNA lipoplexes at a nanometric scale. Nucleic Acids Res. 2010; 39(4):1595-609. PMC: 3045597. DOI: 10.1093/nar/gkq921. View

17.

Palumbo R, Zhong X, Panus D, Han W, Ji W, Wang C . Transgene expression and local tissue distribution of naked and polymer-condensed plasmid DNA after intradermal administration in mice. J Control Release. 2012; 159(2):232-9. PMC: 3351500. DOI: 10.1016/j.jconrel.2012.01.012. View

18.

Kawase A, Nomura T, Yasuda K, Kobayashi N, Hashida M, Takakura Y . Disposition and gene expression characteristics in solid tumors and skeletal muscle after direct injection of naked plasmid DNA in mice. J Pharm Sci. 2003; 92(6):1295-304. DOI: 10.1002/jps.10392. View

19.

Qi R, Gao Y, Tang Y, He R, Liu T, He Y . PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression. AAPS J. 2009; 11(3):395-405. PMC: 2758109. DOI: 10.1208/s12248-009-9116-1. View

20.

Chang C, Choi D, Kim W, Yockman J, Christensen L, Kim Y . Non-ionic amphiphilic biodegradable PEG-PLGA-PEG copolymer enhances gene delivery efficiency in rat skeletal muscle. J Control Release. 2007; 118(2):245-53. DOI: 10.1016/j.jconrel.2006.11.025. View